Cypherpunk Technologies Inc. (CYPH): Operating Income
-$41.07M
Year ended 2025-12-31
-$17.77M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$41.07M | n/m | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | -$70.06M | n/m | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | -$87.04M | n/m | 2025-03-26, From 2023-01-01 |
| 2022-12-31 | -$56.76M | n/m | 2024-03-18, From 2022-01-01 |
| 2021-12-31 | -$41.43M | n/m | 2023-03-24, From 2021-01-01 |
| 2020-12-31 | -$28.54M | n/m | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | -$33.45M | n/m | 2021-03-12, From 2019-01-01 |
| 2018-12-31 | -$30.75M | n/m | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | -$32.35M | n/m | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$27.30M | n/a | 2018-02-23, From 2016-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Cypherpunk Technologies Inc. (CYPH) | 2025-12-31 | -$41.07M | n/m |
| Transcode Therapeutics, Inc. (RNAZ) | 2025-12-31 | -$27.98M | n/m |
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2025-12-31 | -$11.91M | n/m |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | -$76.38M | n/m |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | -$71.05M | n/m |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $11.49M | -28.9% |
| Climb Bio, Inc. (CLYM) | 2025-12-31 | -$67.88M | n/m |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | -$85.31M | n/m |
| Boundless Bio, Inc. (BOLD) | 2025-12-31 | -$63.55M | n/m |
Compare CYPH, RNAZ, APUS, ACRS side by side · Screen every company in Pharmaceutical Preparations ↗